Advanced search

Antisaccadic effects of a dopamine agonist as add-on therapy in advanced Parkinson's patients.

(2000) NEUROPSYCHOBIOLOGY. 42(4). p.202-206
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Crevits, Luc, JAN VERSIJPT, M HANSE, and K DE RIDDER. 2000. “Antisaccadic Effects of a Dopamine Agonist as Add-on Therapy in Advanced Parkinson’s Patients.” Neuropsychobiology 42 (4): 202–206.
APA
Crevits, Luc, VERSIJPT, J., HANSE, M., & DE RIDDER, K. (2000). Antisaccadic effects of a dopamine agonist as add-on therapy in advanced Parkinson’s patients. NEUROPSYCHOBIOLOGY, 42(4), 202–206.
Vancouver
1.
Crevits L, VERSIJPT J, HANSE M, DE RIDDER K. Antisaccadic effects of a dopamine agonist as add-on therapy in advanced Parkinson’s patients. NEUROPSYCHOBIOLOGY. 2000;42(4):202–6.
MLA
Crevits, Luc, JAN VERSIJPT, M HANSE, et al. “Antisaccadic Effects of a Dopamine Agonist as Add-on Therapy in Advanced Parkinson’s Patients.” NEUROPSYCHOBIOLOGY 42.4 (2000): 202–206. Print.
@article{126178,
  author       = {Crevits, Luc and VERSIJPT, JAN and HANSE, M and DE RIDDER, K},
  issn         = {0302-282X},
  journal      = {NEUROPSYCHOBIOLOGY},
  language     = {eng},
  number       = {4},
  pages        = {202--206},
  title        = {Antisaccadic effects of a dopamine agonist as add-on therapy in advanced Parkinson's patients.},
  volume       = {42},
  year         = {2000},
}

Web of Science
Times cited: